Aer Therapeutics is a startup based in the United States, most recent round Series A, 1 tracked investor.
Aer Therapeutics is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Developer of inhaled therapeutics designed to treat severe pulmonary diseases. The company's therapeutics focuses on diseases including pulmonary hypertension and cystic fibrosis, providing patients with targeted therapies to enhance the quality of life.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.